Dabigatran Impurity 118 | CAS 1894988-80-7 - Request Quote
Dabigatran Impurity 118
| SZ CAT No: | SZ-D012246 |
| CAS No | 1894988-80-7 |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. |
180.2 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 118 is chemically Methyl 3-(pyridin-2-ylamino)propanoate. Dabigatran Impurity 118 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 118 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1894988-80-7
Purchase 1894988-80-7
Order 1894988-80-7
Enquire 1894988-80-7
price of 1894988-80-7
1894988-80-7 Supplier
1894988-80-7 Manufacturer
1894988-80-7 Exporter
buy high quality Dabigatran Impurity 118
Purchase Dabigatran Impurity 118
Dabigatran Impurity 118 suppliers
Dabigatran Impurity 118 manufacturers
Dabigatran Impurity 118 price
Order Dabigatran Impurity 118
Enquire Dabigatran Impurity 118
Dabigatran Impurity 118 cost
Dabigatran Impurity 118 Supplier
Dabigatran Impurity 118 Distributor
Dabigatran Impurity 118 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 118 for ANDA Filing
Dabigatran Impurity 118 for Forced Degradation Studies
Dabigatran Impurity 118 Identification Standards
Dabigatran Impurity 118 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.